Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance

Sickle cell disease (SCD) is a severe monogenic disease associated with high morbidity, mortality, and a disproportionate burden on Black and Hispanic communities. Our objective was to estimate the total healthcare costs and out-of-pocket (OOP) costs attributable to SCD among commercially insured in...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Kate M., Jiao, Boshen, Ramsey, Scott D., Bender, M. A., Devine, Beth, Basu, Anirban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Health Services and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898623/
https://www.ncbi.nlm.nih.gov/pubmed/35575558
http://dx.doi.org/10.1182/bloodadvances.2021006281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898623/
https://www.ncbi.nlm.nih.gov/pubmed/35575558
http://dx.doi.org/10.1182/bloodadvances.2021006281

Ejemplares similares